The T2Candida panel and the T2Dx Instrument are for the direct detection of Candida species in human whole blood specimens from patients with symptoms of invasive fungal infections or with conditions that predispose them to such infections.
The T2Candida panel detects Candida albicans, Candida tropicalis, Candida parapsilosis, Candida glabrata, and Candida krusei. The FDA said that the panel is the first direct blood test for detecting the five yeast pathogens.
According to the agency, traditional methods of detecting yeast pathogens in the bloodstream can take up to six days and identifying the specific type of yeast present in the bloodstream may take even longer. By comparison, the T2Candida panel and T2Dx Instrument can identify the five common yeast pathogens from a single blood specimen within three to five hours.
"By testing one blood sample for five yeast pathogens — and getting results within a few hours — physicians can initiate appropriate anti-fungal treatment earlier, and potentially reduce patient illness and decrease the risk of dying from these infections,"
Read more
FDA Clears T2 Bio Test, System for Identification of Yeast Pathogens'
T2Biosystems web page
Source: Genome web
No comments:
Post a Comment